Generic Drug News and Research

RSS

Generic Drugs are official nonbrand names by which medicines are known. Generic names usually refer to the chemical name of the drug.

KHN’s ‘What the Health?’: Delta blues

The U.S. is experiencing another surge of covid-19, particularly in Southern states where vaccination rates are generally lower than in other regions. But partisan fights rage on over what role government should play in trying to tamp down the highly contagious delta variant.

5 Aug 2021

Could fenofibrate be an effective antiviral against SARS-CoV-2?

The resurgence of COVID-19 pandemic, caused by the SARS-CoV-2, has led to renewed efforts to find effective antivirals, both newly developed or repurposed drugs. A study reports the efficacy of the cholesterol-reducing drug fenofibrate in reducing infection rates of SARS-CoV-2 in cultured cells.

13 Jan 2021

FDA approves first generic glucagon for injection to treat severe hypoglycemia

Today, the U.S. Food and Drug Administration approved the first generic of glucagon for injection USP, 1 mg/vial packaged in an emergency kit, for the treatment of severe hypoglycemia (very low blood sugar), which may occur in patients with diabetes mellitus.

28 Dec 2020

Early clinical data demonstrates the efficacy of existing drug in treating COVID-19

In what has the potential to significantly change how Corona patients are being treated and the severity of the disease, research spearheaded at Jerusalem's Hebrew University gathered early clinical evidence demonstrating the efficacy of an existing drug in treating COVID-19.

22 Dec 2020

Hydroxychloroquine not associated with prolonged heart rhythm intervals in RA or lupus patients

New research presented at ACR Convergence, the American College of Rheumatology's annual meeting, discovers that use of hydroxychloroquine, a generic drug, does not cause any significant differences in QTc length or prolonged QTc, key measures of heart rate, in people with rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE).

6 Nov 2020

DARPA selects Purdue-affiliated company to develop continuous manufacturing technology

The COVID-19 pandemic has created supply chain gaps in critical drug products, especially those needed for the most critical patients in intensive care units across the country.

7 Oct 2020

University of Minnesota receives funding to initiate research on diabetes drug as a COVID-19 treatment

University of Minnesota Medical School researchers received funding from the Parsemus Foundation to initiate research on the widely-used diabetes medication, metformin, available globally as an inexpensive generic drug for prevention and treatment for COVID-19.

25 Sep 2020

Reformulated generic drug could offer a cost-effective way to accelerate recovery, prevent hospitalizations

Reformulated and patented version of well-known generic drug could prove to be a quick, safe and cost-effective way to accelerate recovery and prevent hospitalizations.

3 Sep 2020

Medicare Part D insurance plans largely favor generics over brand-name drugs

Contrary to previous media reports, a new study led by Vanderbilt University Medical Center researchers finds that Medicare Part D prescription drug insurance plans largely favor generic drugs over brand-name counterparts.

5 Aug 2020

KHN’s ‘What the Health?’: Republicans in COVID disarray

President Donald Trump's pivot to a more serious view of the coronavirus pandemic didn't last long. This week, he was again touting hydroxychloroquine, an antimalarial drug that has not been shown to work against the virus.

30 Jul 2020

Study shows generic drug does not slow kidney disease

Historically, half or more of people with type 1 diabetes develop kidney disease, which frequently progresses to kidney failure, requiring dialysis treatment or kidney transplantation for survival, according to a study in Diabetes Care.

26 Jun 2020

Promising treatment does not guard against complication in type 1 diabetes

Historically, half or more of people with type 1 diabetes develop kidney disease, which frequently progresses to kidney failure requiring hemodialysis or a kidney transplant for survival.

25 Jun 2020

UEA research recommends changes to prevent controversial pharmaceutical deals

New research from the University of East Anglia (UEA) recommends changes to the system which sees drug companies strike deals with competitors to stop them producing cheaper generic alternatives.

21 May 2020

Olanzapine drug can help manage nausea and vomiting in patients with advanced cancer

Olanzapine, a generic drug used to treat nervous, emotional and mental conditions, also may help patients with advanced cancer successfully manage nausea and vomiting unrelated to chemotherapy.

8 May 2020

High cost of insulin has life-threatening implications for patients with Type 1 diabetes

The most commonly used forms of insulin cost 10 times more in the U.S. than in any other developed country, according to a commentary in Mayo Clinic Proceedings.

2 Jan 2020

PERL study: Reducing uric acid levels does not benefit type 1 diabetes patients with kidney disease

Diabetic kidney disease remains one of the most intractable complications of diabetes. Progress has been made using glycemic and blood pressure control, but the search continues for improved treatments for the estimated one in four adults with diabetes who has some level of nephropathy and continues at risk for eventual kidney failure.

10 Nov 2019

Generic Drug News and Research

Further Reading

KHN’s ‘What the Health?’: Delta blues

Could fenofibrate be an effective antiviral against SARS-CoV-2?

FDA approves first generic glucagon for injection to treat severe hypoglycemia

Early clinical data demonstrates the efficacy of existing drug in treating COVID-19

Hydroxychloroquine not associated with prolonged heart rhythm intervals in RA or lupus patients

DARPA selects Purdue-affiliated company to develop continuous manufacturing technology

University of Minnesota receives funding to initiate research on diabetes drug as a COVID-19 treatment

Reformulated generic drug could offer a cost-effective way to accelerate recovery, prevent hospitalizations

Medicare Part D insurance plans largely favor generics over brand-name drugs

KHN’s ‘What the Health?’: Republicans in COVID disarray

Study shows generic drug does not slow kidney disease

Promising treatment does not guard against complication in type 1 diabetes

UEA research recommends changes to prevent controversial pharmaceutical deals

Olanzapine drug can help manage nausea and vomiting in patients with advanced cancer

High cost of insulin has life-threatening implications for patients with Type 1 diabetes

PERL study: Reducing uric acid levels does not benefit type 1 diabetes patients with kidney disease

Nichi-Iko and Eisai sign collaboration deal for generic pharmaceutical business in China

KHN’s ‘What the Health?’: Tennessee seeks Medicaid changes

Shopping abroad for cheaper medication? Here’s what you need to know

Price of snakebite drug is sky high, but new competitor unlikely to lower costs

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News